16 results
6-K
EX-99.1
PRFX
PainReform Ltd
29 Jul 22
Investor Presentation July 2022
4:30pm
, MBA, Chief Operating Officer ▪ Over 20 years of managerial experience in the Biotech industry. ▪ Former chief R&D officer at MediWound, a company
20-F
2020 FY
PRFX
PainReform Ltd
18 Mar 21
Annual report (foreign)
9:03am
Operating Officer since 2014. Dr. Aviel held the position of Chief R&D Officer at MediWound Ltd. (NASDAQ:MDWD), a company specializing in deep burns
6-K
EX-99.1
PRFX
PainReform Ltd
5 Jan 21
Investor Presentation January 2021
4:15pm
, PhD, MBA. Chief Operating Officer ▪ Over 20 years of managerial experience in the Biotech industry. ▪ Former Chief R&D Officer at MediWound
424B3
nqfmo3gs1a kw
25 Nov 20
Prospectus supplement
11:12am
6-K
EX-99.1
fia7r9
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
424B4
1spw94sf5xdw3p0
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
fffm7 2hry
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
g1hhr
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
xot6j5t1d
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
a5gppbk3
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
ry69gos5gc0vn943cs6
30 Jun 20
Registration statement (foreign)
5:16pm
DRS/A
3yb4gmsy
2 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
xa343uc 9mwq667f3q
12 May 20
Draft registration statement (amended)
12:00am
DRS
7akui1 9l
3 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next